FindTrial
Sign In

Evaluation of the salivary viral load of patients with Covid-19

Evaluation of the impact of the mouthwash and gargle with chlorexidin digluconate on the salivar viral load of patients with covid-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3q6wqdf
Enrollment
Unknown
Registered
2021-03-17
Start date
2020-12-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infections

Interventions

The objective is to evaluate, through the Polymerase Chain Reaction with Real Time Reverse Transcriptase (rRT-PCR), the impact of rinsing and gargling with chlorhexidine digluconate on the salivary vi
Exclusion criteria: Voluntary negative IGM, positive IGM concomitant with positive IGG, suggesting late disease course, and positive IGG confirming immunity. The study will consist of 100 individuals,
D02.078.370.141.100
E05.393.620.500.725

Sponsors

Faculdade de Odontologia da Universidade Federal da Bahia
Lead Sponsor
Secretaria Municipal de Saúde - SMS
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult volunteers; over 18 years of age; of both genders; users of the Unified Health System and diagnosed with Covid19 through rapid testing.

Exclusion criteria

Exclusion criteria: Minors; volunteers not diagnosed with Covid19 after applying a rapid test for the disease.

Design outcomes

Primary

MeasureTime frame
It is expected that the mouthwash and gargle with chlorhexidine digluconate will be able to reduce the salivary viral load in volunteers with Covid-19, and that this result will contribute to the establishment of a service guideline in dental practice.—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactDenis Costa
denisdont@hotmail.com+55071991224543

Outcome results

None listed

Source: REBEC (via WHO ICTRP)